Congress Asset Management Co. Makes New Investment in Encompass Health Corporation $EHC

Key Points

• Congress Asset Management Co. acquired a new stake in Encompass Health Corporation, purchasing 755,862 shares valued at approximately $92.69 million, representing about 0.75% ownership of the company.
• Encompass Health reported quarterly earnings of $1.40 per share, surpassing analysts' estimates of $1.20, alongside a 12.0% year-over-year revenue growth.
• The company announced a quarterly dividend increase to $0.19 per share, reflecting a 0.6% dividend yield, with a payout ratio of 13.31%.

Congress Asset Management Co. acquired a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 755,862 shares of the company's stock, valued at approximately $92,691,000. Congress Asset Management Co. owned approximately 0.75% of Encompass Health as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Pinnacle Wealth Planning Services Inc. increased its stake in Encompass Health by 4.0% during the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock worth $263,000 after buying an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in shares of Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after buying an additional 115 shares during the last quarter. UMB Bank n.a. raised its position in Encompass Health by 10.9% in the second quarter. UMB Bank n.a. now owns 1,187 shares of the company's stock valued at $146,000 after purchasing an additional 117 shares during the period. Arlington Trust Co LLC lifted its position in Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after buying an additional 125 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in shares of Encompass Health by 1.9% during the 2nd quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company's stock worth $993,000 after purchasing an additional 152 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Down 0.2%

NYSE EHC opened at $125.51 on Friday. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.86. The firm has a 50 day moving average of $119.27 and a two-hundred day moving average of $114.34. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $12.64 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 2.20 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company's revenue was up 12.0% on a year-over-year basis. During the same period last year, the business earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is an increase from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is currently 13.31%.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have commented on EHC. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. KeyCorp increased their target price on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 16th. Truist Financial lifted their target price on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. UBS Group increased their price target on shares of Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. According to data from MarketBeat, Encompass Health has a consensus rating of "Buy" and a consensus target price of $138.43.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.